Search
News & Events
Our country kids are doing wellResearch has shown that no matter where our patients reside in WA, whether it be remote or metropolitan based, the ongoing management of diabetes is the same.
News & Events
Diabetes Camp changes for 2016-2017You may have heard we're moving to our new home at Perth Children's Hospital later this year, sadly this means we've had to cancel our camps.
News & Events
Smartphone donationsThe Diabetes Research Team is requesting donations of old iPhones for a new study investigating the effect of real time CGM on every day diabetes management.
News & Events
Diabete$ Re$earch in Au$traliaIt may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes
News & Events
Low Carbohydrate DietsCarbohydrate restriction is used by some individuals with type 1 diabetes to reduce glucose excursions after eating a meal.
News & Events
Recruitment for AdDIT now completeYoung people diagnosed with Type 1 Diabetes are at risk of complications from their diabetes including kidney, heart, eye and vascular disease.
News & Events
WA teenager with type 1 diabetes on a mission to become a pro-cyclistA wiry tall teenager, who was struggling somewhat with his blood glucose control, he turned up on his trusty bike, and we had something in common to talk about.
T1D can be a traumatic diagnosis for children and young people, and often involves strict adherence to painful treatments, comorbid mental health conditions, and shortened life expectancy.
News & Events
Cholesterol and blood pressure drugs help teens with diabetesThe study involved screening young people to learn more about the development of long-term kidney, eye and cardiovascular complications in adolescents with T1D.
Research
Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global PerspectiveGlobally, nearly 9 million people are living with type 1 diabetes (T1D). Although the incidence of T1D is not affected by socioeconomic status, the development of complications and limited access to modern therapy is overrepresented in vulnerable populations. Diabetes technology, specifically continuous glucose monitoring and automated insulin delivery systems, are considered the gold standard for management of T1D, yet access to these technologies varies widely across countries and regions, and varies widely even within high-income countries.